Visken; Prinodolol; Betapindol; Carvisken; Durapindol; Pinbetol; Calvisken; Decreten; Pectobloc; Pynastin; Blocklin L; LB-46; Pindololum; Glauco-visken; Blockin L; LB 46; Blocklin-L; 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole; l-Pindolol; 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol; 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole; 2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-; Glauco-Viskin; NCGC00015786-11; (+-)-Pindolol; DSSTox_CID_3476; DL-Pindolol; Pindololum [INN-Latin]; (-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol; DSSTox_RID_77043; DSSTox_GSID_23476; Blocklin; Carvisken (TN); SMR000059120; Blocklin-L (TN); Visken (TN); CCRIS 9215; HSDB 6539; SR-01000000027; EINECS 236-867-9; EINECS 244-623-8; BRN 1536506; DL-LB 46; Prestwick_397; Pindolol [USAN:USP:INN:BAN:JAN]; Spectrum_001109; (.+/-.)-Pindolol; Prestwick0_000090; Prestwick1_000090; Prestwick2_000090; Prestwick3_000090; Spectrum2_001285; Spectrum3_000547; Spectrum4_000479; Spectrum5_001266; (R,S)-PINDOLOL; CHEMBL500; GTPL91; PINDOLOL,(-); P 0778; P-6820; SCHEMBL5219; Lopac0_000955; Oprea1_770884; BSPBio_000020; BSPBio_002193; KBioGR_000958; KBioSS_001589; 5-21-03-00017 (Beilstein Handbook Reference); DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; MLS000069496; MLS002548891; DivK1c_000837; SPECTRUM1500488; Pindolol (JP17/USP/INN); SPBio_001289; SPBio_001959; BPBio1_000022; DTXSID8023476; CTK8G2432; HMS502J19; KBio1_000837; KBio2_001589; KBio2_004157; KBio2_006725; KBio3_001693; NINDS_000837; HMS1568A22; HMS1920H16; HMS2089I21; HMS2091P20; HMS2095A22; HMS3259I07; HMS3262P12; HMS3267K17; HMS3369E14; HMS3414J03; HMS3678H21; HMS3712A22; HMS3742C07; HMS3885N04; Pharmakon1600-01500488; HY-B0982; Pindolol, >=98% (TLC), powder; Tox21_110221; Tox21_500955; BDBM50019443; CCG-39223; MFCD00010530; NSC757276; PDSP1_000771; PDSP1_000772; PDSP2_000759; PDSP2_000760; (+/-)-Pindolol-d7(iso-propyl-d7); AKOS015969756; Tox21_110221_1; CS-4473; DB00960; LP00955; MCULE-7764948919; NC00467; NSC-757276; SDCCGSBI-0050929.P005; IDI1_000837; NCGC00015786-06; NCGC00015786-07; NCGC00015786-08; NCGC00015786-09; NCGC00015786-10; NCGC00015786-13; NCGC00015786-14; NCGC00015786-16; NCGC00015786-20; NCGC00015786-22; NCGC00024925-03; NCGC00024925-04; NCGC00024925-05; NCGC00024925-06; NCGC00024925-07; NCGC00261640-01; SC-25688; SBI-0050929.P004; AB00052072; EU-0100955; FT-0673907; ST50319990; SW196641-3; Z3376; C07445; D00513; AB00052072-11; AB00052072_12; AB00052072_13; 1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol; 523P869; L000006; Q418101; 3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol; SR-01000000027-2; SR-01000000027-4; SR-01000000027-5; SR-01000000027-7; 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol; BRD-A97701745-001-05-3; BRD-A97701745-001-09-5